Active Ingredient History
The drug combination bismuth subcitrate/metronidazole/tetracycline is used for the treatment of peptic ulcer with an infection by the bacterium Helicobacter pylori. It is taken by mouth. Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bacterial Infections (Phase 3)
Dysbiosis (Phase 4)
Dyspepsia (Phase 4)
Gastritis (Early Phase 1)
Helicobacter Infections (Phase 4)
Helicobacter pylori (Phase 4)
Lymphoma (Phase 2)
Peptic Ulcer (Phase 4)
Probiotics (Phase 4)
Sprains and Strains (Phase 3)
Stomach Diseases (Phase 4)
Stomach Neoplasms (Early Phase 1)
Stomach Ulcer (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue